This study explored the anti-inflammatory and anti-metastatic properties of morin in non-small-cell lung cancer (NSCLC) cells, focusing on its effects on the NLRP3 inflammasome and MAPK signaling pathways. This evidence concerns the gene NLRP3 and non-small cell lung carcinoma.